Molecules and Cells

Korean Society for Molecular and Cellular Biology (한국분자세포생물학회)
권호 표지
DOI QR코드

DOI QR Code

Involvement of RUNX and BRD Family Members in Restriction Point

  • Lee, Jung-Won (Department of Biochemistry, College of Medicine, Chungbuk National University) ;
  • Park, Tae-Geun (Department of Biochemistry, College of Medicine, Chungbuk National University) ;
  • Bae, Suk-Chul (Department of Biochemistry, College of Medicine, Chungbuk National University)
  • Received : 2019.11.05
  • Accepted : 2019.11.06
  • Published : 2019.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

A tumor is an abnormal mass of tissue that arises when cells divide more than they should or do not die when they should. The cellular decision regarding whether to undergo division or death is made at the restriction (R)-point. Consistent with this, an increasingly large body of evidence indicates that deregulation of the R-point decision-making machinery accompanies the formation of most tumors. Although the R-point decision is literally a matter of life and death for the cell, and thus critical for the health of the organism, it remains unclear how a cell chooses its own fate. Recent work demonstrated that the R-point constitutes a novel oncogene surveillance mechanism operated by R-point-associated complexes of which RUNX3 and BRD2 are the core factors (Rpa-RX3 complexes). Here, we show that not only RUNX3 and BRD2, but also other members of the RUNX and BRD families (RUNX1, RUNX2, BRD3, and BRD4), are involved in R-point regulation.

Keywords

References

  1. Belkina, A.C. and Denis, G.V. (2012). BET domain co-regulators in obesity, inflammation and cancer. Nat. Rev. Cancer 12, 465-477. https://doi.org/10.1038/nrc3256
  2. Cheung, K.L., Zhang, F., Jaganathan, A., Sharma, R., Zhang, Q., Konuma, T., Shen, T., Lee, J.Y., Ren, C., Chen, C.H., et al. (2017). Distinct roles of Brd2 and Brd4 in potentiating the transcriptional program for Th17 cell differentiation. Mol. Cell 65, 1068-1080.e5. https://doi.org/10.1016/j.molcel.2016.12.022
  3. Chi, X.Z., Lee, J.W., Lee, Y.S., Park, I.Y., Ito, Y., and Bae, S.C. (2017). Runx3 plays a critical role in restriction-point and defense against cellular transformation. Oncogene 36, 6884-6894. https://doi.org/10.1038/onc.2017.290
  4. Filippakopoulos, P., Picaud, S., Mangos, M., Keates, T., Lambert, J.P., Barsyte-Lovejoy, D., Felletar, I., Volkmer, R., Muller, S., Pawson, T., et al. (2012). Histone recognition and large-scale structural analysis of the human bromodomain family. Cell 149, 214-231. https://doi.org/10.1016/j.cell.2012.02.013
  5. Huang, H., Zhang, J., Shen, W., Wang, X., Wu, J., and Shi, Y. (2007). Solution structure of the second bromodomain of Brd2 and its specific interaction with acetylated histone tails. BMC Struct. Biol. 7, 57. https://doi.org/10.1186/1472-6807-7-57
  6. Ito, Y. (2008). RUNX genes in development and cancer: regulation of viral gene expression and the discovery of RUNX family genes. Adv. Cancer Res. 99, 33-76. https://doi.org/10.1016/S0065-230X(07)99002-8
  7. Ito, Y., Bae, S.C., and Chuang, L.S. (2015). The RUNX family: developmental regulators in cancer. Nat. Rev. Cancer 15, 81-95. https://doi.org/10.1038/nrc3877
  8. Lee, J.W., Kim, D.M., Jang, J.W., Park, T.G., Song, S.H., Lee, Y.S., Chi, X.Z., Park, I.Y., Hyun, J.W., Ito, Y., et al. (2019). RUNX3 regulates cell cycle-dependent chromatin dynamics by functioning as a pioneer factor of the restrictionpoint. Nat. Commun. 10, 1897. https://doi.org/10.1038/s41467-019-09810-w
  9. Lee, Y.S., Lee, J.W., Jang, J.W., Chi, X.Z., Kim, J.H., Li, Y.H., Kim, M.K., Kim, D.M., Choi, B.S., Kim, E.G., et al. (2013). Runx3 inactivation is a crucial early event in the development of lung adenocarcinoma. Cancer Cell 24, 603-616. https://doi.org/10.1016/j.ccr.2013.10.003
  10. LeRoy, G., Rickards, B., and Flint, S.J. (2008). The double bromodomain proteins Brd2 and Brd3 couple histone acetylation to transcription. Mol. Cell 30, 51-60. https://doi.org/10.1016/j.molcel.2008.01.018
  11. Malumbres, M. and Barbacid, M. (2001). To cycle or not to cycle: a critical decision in cancer. Nat. Rev. Cancer 1, 222-231. https://doi.org/10.1038/35106065
  12. Mangan, J.K. and Speck, N.A. (2011). RUNX1 mutations in clonal myeloid disorders: from conventional cytogenetics to next generation sequencing, a story 40 years in the making. Crit. Rev. Oncog. 16, 77-91. https://doi.org/10.1615/CritRevOncog.v16.i1-2.80
  13. Pardee, A.B. (1974). A restriction point for control of normal animal cell proliferation. Proc. Natl. Acad. Sci. U. S. A. 71, 1286-1290. https://doi.org/10.1073/pnas.71.4.1286
  14. Pratap, J., Lian, J.B., Javed, A., Barnes, G.L., van Wijnen, A.J., Stein, J.L., and Stein, G.S. (2006). Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone. Cancer Metastasis Rev. 25, 589-600. https://doi.org/10.1007/s10555-006-9032-0
  15. Taniguchi, Y. (2016). The bromodomain and extra-terminal domain (BET) family: functional anatomy of BET paralogous proteins. Int. J. Mol. Sci. 17, E1849. https://doi.org/10.3390/ijms17111849
  16. Weinberg, R.A. (2007). pRB and control of the cell cycle clock. In The Biology of Cancer, R.A. Weinberg, ed. (New York: Garland Science), pp. 275-329.
  17. Zaret, K.S. and Carroll, J.S. (2011). Pioneer transcription factors: establishing competence for gene expression. Genes Dev. 25, 2227-2241. https://doi.org/10.1101/gad.176826.111
  18. Zetterberg, A., Larsson, O., and Wiman, K.G. (1995). What is the restriction point? Curr. Opin. Cell Biol. 7, 835-842. https://doi.org/10.1016/0955-0674(95)80067-0

Cited by

  1. Role of RUNX Family Members in G1 Restriction-Point Regulation vol.43, pp.2, 2019, https://doi.org/10.14348/molcells.2019.0319